Clinical trial
The FIRSTT Study: Comparing Focused Ultrasound and Uterine Artery Embolization for Uterine Fibroids
NCT00995878 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The FIRSTT Study: Comparing Focused Ultrasound and Uterine Artery Embolization for Uterine Fibroids
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 29, 2010
- Completion date
- December 31, 2017
- Enrollment
- 56 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
fibroids, myomas, symptomatic uterine leiomyomas, uterine fibroids